ETS Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
ETS is not a good buy right now for a beginner with a long-term focus and $50,000-$100,000 to invest. The stock is trading below key moving averages with negative momentum, there is no proprietary buy signal today, and recent news plus weak profitability make the setup unattractive. Based on the data provided, the clear choice is to avoid buying and not commit capital here now.
ETS is in a bearish trend. The moving averages are stacked bearishly with SMA_200 > SMA_20 > SMA_5, which confirms downside pressure. MACD histogram is negative and still expanding lower, showing weakening momentum. RSI_6 at 37.834 is neutral-to-weak and does not indicate a strong rebound. Price at 0.57 is below the pivot of 0.597, with near support at 0.514; resistance is at 0.679, so the current chart favors caution rather than entry.
Revenue in Q1 2026 grew 16.35% year over year to 805,298, showing top-line expansion. Similar-pattern stock trend data also suggests a modest short-term rebound probability, with estimates of 1.91% next day, 0.91% next week, and 3.71% next month. However, these are not strong enough to override the broader bearish setup.
The Schall Law Firm launched an investigation into ETS on 2026-04-27, which can hurt investor confidence. Net income remained negative at -110,104 and declined 46.29% YoY, showing worsening profitability. Gross margin also fell sharply to 19.54, indicating weak operating quality. Hedge funds and insiders are both neutral, so there is no supportive buying trend from informed holders. No recent congress trading data is available, and there are no bullish AI Stock Picker or SwingMax signals.
In Q1 2026, ETS posted revenue of 805,298, up 16.35% YoY, which is a positive growth sign. But net income was -110,104, down 46.29% YoY, so losses widened. EPS was -0.01, still negative, and gross margin dropped to 19.54, suggesting the company is growing sales but not converting them into profit. Overall, the latest quarter shows weak financial quality despite revenue growth.
No analyst rating or price target change data was provided. The wall street view available from the dataset is mixed-to-negative: there is some revenue growth, but losses, margin deterioration, a legal investigation, and bearish technicals outweigh any positive outlook. With no reported analyst upgrades or target increases, sentiment appears unimpressive.
